Obesity and its nurturing effect on hepatitis C.
McCullough
Arthur J
AJ
D000998:Antiviral Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001682:Biological Availability; D004351:Drug Resistance; D005234:Fatty Liver / Q000150:complications / Q000503:physiopathology; D006526:Hepatitis C / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D007107:Immune System / Q000503:physiopathology; D007372:Interferons / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D020738:Leptin / Q000378:metabolism; D008099:Liver / Q000503:physiopathology; D009765:Obesity / Q000150:complications* / Q000276:immunology; D017211:Treatment Failure
D000998:Antiviral Agents; D020738:Leptin; D007372:Interferons